KONTAN.CO.ID - BEIJING. About 90% of Sinovac Biotech Ltd employees and their families have taken an experimental coronavirus vaccine developed by the Chinese firm under the country's emergency use programme, its chief executive said on Sunday. The extent of inoculations under the emergency programme, which China launched in July but has released few details about, points to how actively it is using experimental vaccines in the hopes of protecting essential workers against a potential COVID-19 resurgence, even as trials are still underway. The programme is intended for specific groups, including medical staffers and those who work at food markets and in the transportation and service sectors.
90% of China's Sinovac employees, families took coronavirus vaccine-CEO
KONTAN.CO.ID - BEIJING. About 90% of Sinovac Biotech Ltd employees and their families have taken an experimental coronavirus vaccine developed by the Chinese firm under the country's emergency use programme, its chief executive said on Sunday. The extent of inoculations under the emergency programme, which China launched in July but has released few details about, points to how actively it is using experimental vaccines in the hopes of protecting essential workers against a potential COVID-19 resurgence, even as trials are still underway. The programme is intended for specific groups, including medical staffers and those who work at food markets and in the transportation and service sectors.